Authors: Gururangan, S Cokgor, I Rich, JN Edwards, S Affronti, ML Quinn, JA Herndon, JE Provenzale, JM McLendon, RE Tourt-Uhlig, S Sampson, JH Stafford-Fox, V Zaknoen, S Early, M Friedman, AH Friedman, HS

Citation: S. Gururangan et al., Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas, NEURO-ONCOL, 3(4), 2001, pp. 246-250

Authors: Brada, M Hoang-Xuan, K Rampling, R Dietrich, PY Dirix, LY Macdonald, D Heimans, JJ Zonnenberg, BA Bravo-Marques, JM Henriksson, R Stupp, R Yue, N Bruner, J Dugan, M Rao, S Zaknoen, S

Citation: M. Brada et al., Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse, ANN ONCOL, 12(2), 2001, pp. 259-266

Authors: Yung, WKA Albright, RE Olson, J Fredericks, R Fink, K Prados, MD Brada, M Spence, A Hohl, RJ Shapiro, W Glantz, M Greenberg, H Selker, RG Vick, NA Rampling, R Friedman, H Phillips, P Bruner, J Yue, N Osoba, D Zaknoen, S Levin, VA

Citation: Wka. Yung et al., A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse, BR J CANC, 83(5), 2000, pp. 588-593

Authors: Yung, WKA Prados, MD Yaya-Tur, R Rosenfeld, SS Brada, M Friedman, HS Albright, R Olson, J Chang, SM O'Neill, AM Friedman, AH Bruner, J Yue, N Dugan, M Zaknoen, S Levin, VA

Citation: Wka. Yung et al., Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse, J CL ONCOL, 17(9), 1999, pp. 2762-2771